Clinical Trials Finder
Independent ClinicalTrials.gov directory
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

ClinicalTrials.gov ID: NCT06346392

Public ClinicalTrials.gov record NCT06346392. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced May 19, 2026, 8:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Multi-center, Open-label, Sponsor-blinded, Randomized Study of AZD0901 Monotherapy Compared With Investigator's Choice of Therapy in Second- or Later-Line Adult Participants With Advanced/Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2 (CLARITY Gastric 01)

Study identification

NCT ID
NCT06346392
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
572 participants

Conditions and interventions

Interventions

  • AZD0901 Drug
  • Apatinib Drug
  • Docetaxel Drug
  • Irinotecan Drug
  • Paclitaxel Drug
  • Ramucirumab+ paclitaxel Drug
  • TAS-102 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 3, 2024
Primary completion
May 13, 2026
Completion
Sep 13, 2026
Last update posted
Mar 8, 2026

2024 – 2026

United States locations

U.S. sites
38
U.S. states
19
U.S. cities
33
Facility City State ZIP Site status
Research Site Birmingham Alabama 35233 Withdrawn
Research Site Mobile Alabama 36604 Active, not recruiting
Research Site Tucson Arizona 85719 Active, not recruiting
Research Site Duarte California 91010 Active, not recruiting
Research Site Fullerton California 92835 Withdrawn
Research Site Irvine California 92618 Active, not recruiting
Research Site Los Angeles California 90048 Active, not recruiting
Research Site Los Angeles California 90089 Active, not recruiting
Research Site Newport Beach California 92663 Recruiting
Research Site Santa Rosa California 95403 Withdrawn
Research Site Washington D.C. District of Columbia 20007 Active, not recruiting
Research Site Fleming Island Florida 32003 Withdrawn
Research Site Hollywood Florida 33021 Active, not recruiting
Research Site Orlando Florida 32804 Active, not recruiting
Research Site Atlanta Georgia 30322 Withdrawn
Research Site Marietta Georgia 30060 Active, not recruiting
Research Site Honolulu Hawaii 96819 Withdrawn
Research Site Boise Idaho 83712 Active, not recruiting
Research Site Lexington Kentucky 40536 Active, not recruiting
Research Site Baltimore Maryland 21287 Withdrawn
Research Site Boston Massachusetts 02114 Active, not recruiting
Research Site Ann Arbor Michigan 48106 Active, not recruiting
Research Site Ann Arbor Michigan 48109 Active, not recruiting
Research Site Kansas City Missouri 64111 Active, not recruiting
Research Site St Louis Missouri 63110 Withdrawn
Research Site St Louis Missouri 63128 Withdrawn
Research Site Mineola New York 11501 Active, not recruiting
Research Site New York New York 10016 Active, not recruiting
Research Site New York New York 10032 Active, not recruiting
Research Site New York New York 10065 Recruiting
Research Site Cincinnati Ohio 45219 Withdrawn
Research Site Portland Oregon 97239 Withdrawn
Research Site Philadelphia Pennsylvania 19111 Active, not recruiting
Research Site York Pennsylvania 17403 Active, not recruiting
Research Site Charlottesville Virginia 22908 Active, not recruiting
Research Site Fredericksburg Virginia 22408 Active, not recruiting
Research Site Olympia Washington 98502 Active, not recruiting
Research Site Seattle Washington 98109 Withdrawn

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 148 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06346392, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 8, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06346392 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →